| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Tivantinib |
|---|
| Description | Tivantinib (ARQ-197) is a potent, cell-permeable inhibitor of c-Met with potential antineoplastic activity. Tivantinib binds to the c-Met protein and disrupts c-Met signal transduction pathways, which may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. MW: 369.41. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione; ARQ197 |
|---|
| Gene, Accession, CAS # | CAS: 905854-02-6 |
|---|
| Catalog # | B1546-5 |
|---|
| Price | |
|---|
| Order / More Info | Tivantinib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|